review · Cureus

Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders

John Olukorode
Chidera Onwuzo
Oluwatobi S Odunaike
Dolapo A Orimoloye
Temiloluwa Fayemi
Nwachukwu O Nwachukwu
Petra S Ayobami-Ojo
Praise O Oloyede
Dominique Alò
Nwachi Divine
C. Alex

202413 citationsOpen accessBabcock University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Diabetes Treatment and Management
Pharmacology and Obesity Treatment
Diabetes Management and Research

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.7759/cureus.72080

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.